Viloxazine: A Nonstimulant Treatment Option for ADHD
Researchers compare viloxazine as a nonstimulant treatment option to atomoxetine for managing inattention, hyperactivity, and impulsivity in pediatric and adult patients with ADHD.
Researchers compare viloxazine as a nonstimulant treatment option to atomoxetine for managing inattention, hyperactivity, and impulsivity in pediatric and adult patients with ADHD.
Although the rise in pediatric obesity predates the COVID-19 pandemic, stressors experienced during the pandemic exposed inequities in children’s health.